Magnetic resonance spectroscopy for breast cancer

Magnetic resonance spectroscopy for breast cancer

ScienceDirect - Gynecologic Oncology : Use of systemic therapy in women with recurrent ovarian cancer—Development of a national clinical practice guid

ScienceDirect - Gynecologic Oncology : Use of systemic therapy in women with recurrent ovarian cancer—Development of a national clinical practice guideline

ScienceDirect - Gynecologic Oncology : Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary

ScienceDirect - Gynecologic Oncology : Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer

Editorial but no free text- Gynecologic Oncology : Time for action: A “sea change” in treatment strategies for rare types of epithelial ovarian cancer

ScienceDirect - Gynecologic Oncology : Time for action: A “sea change” in treatment strategies for rare types of epithelial ovarian cancer

ScienceDirect - European Journal of Cancer : Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

ScienceDirect - European Journal of Cancer : Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriers

ScienceDirect - European Journal of Cancer : Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation

ScienceDirect - European Journal of Cancer : Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation

ScienceDirect - Journal of Pain and Symptom Management : Complications at the End of Life in Ovarian Cancer

ScienceDirect - Journal of Pain and Symptom Management : Complications at the End of Life in Ovarian Cancer

ScienceDirect - Gynecologic Oncology : Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube c

ScienceDirect - Gynecologic Oncology : Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer

ScienceDirect - Gynecologic Oncology : Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for

ScienceDirect - Gynecologic Oncology : Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials

ScienceDirect - Gynecologic Oncology : Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: Results and 5-year fo

ScienceDirect - Gynecologic Oncology : Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: Results and 5-year follow-up

ScienceDirect - Gynecologic Oncology : Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer

ScienceDirect - Gynecologic Oncology : Estrogen-regulated gene expression predicts response to endocrine therapy in patients with ovarian cancer

ScienceDirect - Fertility and Sterility : Safety of testosterone treatment in postmenopausal women

ScienceDirect - Fertility and Sterility : Safety of testosterone treatment in postmenopausal women

Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as an Additional Method in the Selection of Patients --

Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as an Additional Method in the Selection of Patients -- Vaz et al., 10.1369/jhc.7A7209.2007 -- Journal of Histochemistry and Cytochemistry

Germ Cell Cancer - Survivors of rare ovarian cancer retain fertility....

Germ Cell Cancer - Survivors of rare ovarian cancer retain fertility, have p...

Antisoma, Novartis drug fails in ovarian cancer |- Reuters

Antisoma, Novartis drug fails in ovarian cancer | Breaking City News | Reuters.co.uk